Who is sponsoring NCT06130657?

NCT06130657 is sponsored by Ahmed Zewail.

What drugs are being tested in NCT06130657?

Interventions in NCT06130657: Lateral Maxillary Sinus Floor Elevation using surgical guide, Lateral Maxillary Sinus Floor Elevation without surgical guide.

What condition does NCT06130657 study?

NCT06130657 studies Lateral Sinus Lifting, Dental Implant.

Is NCT06130657 still recruiting?

NCT06130657 is currently completed. Last updated 14 November 2023.

Last reviewed 2023-11-14 · How we verify

NCT06130657

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Volumetric Analysis of Maxillary Sinus After Guided Lateral Sinus Lift Procedure

Completed NA Last updated 14 November 2023

What this trial tests

NA trial testing Lateral Maxillary Sinus Floor Elevation using surgical guide in Lateral Sinus Lifting in 14 participants. Completed in 1 February 2023.

Timeline

29 December 2020

Primary endpoint
1 February 2023

1 February 2023

Quick facts

Lead sponsor	Ahmed Zewail
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	14
Start date	29 December 2020
Primary completion	1 February 2023
Estimated completion	1 February 2023
Sites	1 location across Egypt

Drugs / interventions tested

Lateral Maxillary Sinus Floor Elevation using surgical guide
Lateral Maxillary Sinus Floor Elevation without surgical guide

Conditions studied

Lateral Sinus Lifting — all drugs for Lateral Sinus Lifting →
Dental Implant — all drugs for Dental Implant →

Sponsor

Ahmed Zewail

Who can join

18 and older, any sex, with Lateral Sinus Lifting or Dental Implant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to present a guided lateral window sinus lift (GLSL) procedure with the aid of a fully digital workflow using surgical templates for window osteotomy preparation and implant placement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06130657 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ahmed Zewail
Last refreshed: 14 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06130657.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing